Steven Canfield, MD presented “Pew Pew! Laser Applications for Prostate Ablation” during the 2023 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on November 10, 2023, in Chicago, Illinois.
How to cite: Canfield, Steven “Pew Pew! Laser Applications for Prostate Ablation” November, 2023. Accessed Nov 2025. https://grandroundsinurology.com/pew-pew-laser-applications-for-prostate-ablation/
Pew Pew! Laser Applications for Prostate Ablation – Summary
Steven Canfield, MD, examines the innovative use of laser technology for prostate ablation in the management of prostate cancer. Dr. Canfield emphasizes the procedure’s precision, safety, and efficacy, positioning it as a significant advancement in prostate cancer treatment.
Dr. Canfield reviews the mechanisms of laser ablation under real-time imaging guidance, often using ultrasound or MRI. He asserts that this approach allows for the precise targeting of cancerous lesions, reducing the risk of damage to critical anatomical structures such as the neurovascular bundles and urinary sphincter.
Dr. Canfield highlights patient selection criteria and presents clinical outcome data that demonstrates promising results of laser ablation. He addresses the technological advancements that have enhanced the effectiveness and safety of the procedure, including improved imaging techniques and laser delivery systems.
Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies.
ABOUT THE AUTHOR
Steven Canfield, MD, is Chief of Urology at the University of Texas Health Science Center, and holds the Bard/McQuire Distinguished Chair in Urology at McGovern Medical School at UTHealth in Houston, Texas, His clinical interests are in urologic cancers, advanced diagnostics for prostate cancer including genomic testing and MRI fusion targeted biopsy treatment and surveillance for early stage, low-risk prostate cancer, new therapeutics for advanced-stage prostate cancer, minimally invasive kidney-sparing surgery, robotic surgery, minimally invasive prostate surgery including plasma vaporization, men’s health, and comprehensive kidney stone care with advanced technologies.
